Immune-checkpoint inhibitors induced diarrhea and colitis

Volume: 36, Issue: 1, Pages: 25 - 32
Published: Jan 1, 2020
Abstract
Purpose of reviewDiarrhea and colitis are among the most commonly encountered immune-mediated adverse events among patients receiving antiprogrammed cell death protein/ligand-1 (PD-1/L1) as well as anticytotoxic T-lymphocyte-associated protein 4 (CTLA-4) antibodies. With growing indications and...
Paper Details
Title
Immune-checkpoint inhibitors induced diarrhea and colitis
Published Date
Jan 1, 2020
Volume
36
Issue
1
Pages
25 - 32
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.